# An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis

> **NCT03924427** · PHASE3 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 74 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** BMS-986165

## Key facts

- **NCT ID:** NCT03924427
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-10
- **Primary completion:** 2021-03-24
- **Final completion:** 2021-03-24
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2022-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03924427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03924427, "An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03924427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*